-
![[Good News] A subsidiary of Cell Valley Group has successfully obtained China's first FDA DMF filing for a retroviral vector and become the world's first company to receive approval for a Trop2-IL15 v](/Public/Images/nopic/1en.jpg "[Good News] A subsidiary of Cell Valley Group has successfully obtained China's first FDA DMF filing for a retroviral vector and become the world's first company to receive approval for a Trop2-IL15 v")
[Good News] A subsidiary of Cell Valley Group has successfully obtained China's first FDA DMF filing for a retroviral vector and become the world's first company to receive approval for a Trop2-IL15 vChina, Shenzhen, December 2025) — Guangdong JUNJO Pharma Co., Ltd., a wholly-owned subsidiary of Cell Valley Group, officially announced that its GMP-grade GALV...12-09 -
Exclusive research data from Cell Valley reveals that NK exosomes demonstrate superior skin repair potential, positioning them as a promising anti-aging solution for future skin rejuvenation.While the NK cell exosome product became the first in the industry to obtain FDA DMF approval, Shenzhen Cell Valley simultaneously conducted comprehensive safet...12-09
-
[Good News] Shenzhen Cell Valley becomes the world's first company to obtain the Drug Master File (DMF) filing for NK cell-derived exosomes from the U.S. FDA(China Shenzhen, December 2025) — Shenzhen Cell Valley Biomedical Co., Ltd. officially announced that the NK cell-derived exosomes submitted by the company have...12-09
-
Shenzhen Cell Valley and Shenzhen Research Institute of Central South University Forge Industry-University-Research Partnership to Advance Biomedical Innovation and TranslationRecently, the Central South University Greater Bay Area Biomedical Achievement Matchmaking Conference & the 5th Health Innovation and Translation Forum was gran...12-01
-
A delegation from the International Cooperation Center of the National Development and Reform Commission visited Deep Harbour Cell Valley for an inspection.To thoroughly implement the strategic deployment of expanding high-level opening-up as outlined in the Third Plenary Session of the 20th CPC Central Committee, ...12-01
-
Professor Shen Hao, CEO of Baiji Biotech, visited Deep Harbour Cell ValleyOn July 9, 2025, Professor Shen Hao, CEO of Biosyngen China, visited Deep Harbour Cell Valley and was warmly welcomed by the company's founder, Professor Shi Yu...12-01
